No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
IFF240816C50000
- 33.35
- 0.000.00%
15min DelayClose Jul 22 15:56 ET
0.00High0.00Low
33.35Open33.35Pre Close0 Volume0 Open Interest50.00Strike Price0.00Turnover0.00%IV-15.07%PremiumAug 16, 2024Expiry Date48.14Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.03Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
IFF's Leverage to Improve by 2025, Sales Momentum to Boost EBITDA, Projects Analyst
Stifel analyst Mark S. Astrachan upgraded International Flavors & Fragrances Inc. (NYSE:IFF) stock to Buy from Hold with an increased price target of $115 from $95.The analyst sees 2024 guidance as
International Flavors Raised at Stifel Sees Sales Topping Company Guidance
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Goldman
Peeling Back The Layers: Exploring Intl Flavors & Fragrances Through Analyst Insights
Intl Flavors & Fragrances (NYSE:IFF) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below summarizes their recent ratings,
Express News | International Flavors & Fragrances Inc : Stifel Raises to Buy From Hold
Intl Flavors & Fragrances Price Target Raised to $115.00/Share From $95.00 by Stifel
Intl Flavors & Fragrances Price Target Raised to $115.00/Share From $95.00 by
Comments
Morning Movers
Gapping up
$Pfizer(PFE.US$ stock increased by 0.1% as the pharmaceutical giant sold a roughly $3.9 billion stake in the UK-based consumer healthcare company, Haleon, reducing its ownership to 22.6%.
$Spire Global(SPIR.US$ stock jumped 17% following the announcement of a collaboration with Nvidia to leverage AI for enhanced weather prediction.
$Unilever(UL.US$ American Depositary Receipts (ADRs) climbed 2.7% a...
Gapping up
$Pfizer(PFE.US$ stock increased by 0.1% as the pharmaceutical giant sold a roughly $3.9 billion stake in the UK-based consumer healthcare company, Haleon, reducing its ownership to 22.6%.
$Spire Global(SPIR.US$ stock jumped 17% following the announcement of a collaboration with Nvidia to leverage AI for enhanced weather prediction.
$Unilever(UL.US$ American Depositary Receipts (ADRs) climbed 2.7% a...
39
1
Analysts show increased negativity towards the business following recent results, reflected in a minor dip in next year's earnings per share predictions. Despite this, the unchanged consensus price target indicates that lower forecast earnings won't necessarily result in a future stock price drop. The company's revenue growth is expected to decelerate, with a projected annual decline of 3.9% by end of 2024, trailing the broader industry.
1
Morning Movers
Gapping up
$Macy's(M.US$ Shares of the department store giant added 2% in premarket trading after the company over the weekend rejected a $5.8 billion proposal by Arkhouse Management and partner Brigade Capital Management to take the retailer private. Macy’s cited concerns over deal financing and valuation.
$International Flavors & Fragrances(IFF.US$ Shares added 1.9% after Morgan Stanley upgraded the fragrance co...
Gapping up
$Macy's(M.US$ Shares of the department store giant added 2% in premarket trading after the company over the weekend rejected a $5.8 billion proposal by Arkhouse Management and partner Brigade Capital Management to take the retailer private. Macy’s cited concerns over deal financing and valuation.
$International Flavors & Fragrances(IFF.US$ Shares added 1.9% after Morgan Stanley upgraded the fragrance co...
12
Deutsche Bank analysts suggest the company's statement on additional divestiture actions likely refers to a potential sale of its Pharma Solutions business. They see this as the most logical way for the company to meet its '24 net debt-to-EBITDA target of
Despite profitability, ongoing challenges may be shown in the share price decline in the past five years. Unfavorable market trends and warning signals associated with International Flavors & Fragrances could deter potential investors.
Read more
khairulreza : #$NVIDIA (NVDA.US)$